Guest guest Posted May 18, 2011 Report Share Posted May 18, 2011 Dear Friends, This Special Edition of Research & Treatment News is dedicated to World Hepatitis Day, which is Thursday, May 19th. Worldwide, one in 12 people are infected with either Hepatitis B or C. According to the World Hepatitis Alliance, “World Hepatitis Day is an annual event that each year provides international focus for patient groups and people living with Hepatitis B and C. It is an opportunity around which interested groups can raise awareness and influence real change in disease prevention and access to testing and treatment.†To learn more about World Hepatitis Day and the World Hepatitis Alliance – click here. At Hepatitis-Central.com, we are here to help people stay informed about the latest hepatitis and HCV news and breakthroughs, and to provide information on enhancing liver health. Thank you for subscribing to R & T News, and for forwarding this free online newsletter to friends, family, patients, health professionals and caregivers, so others can also stay informed. Boceprevir Approval Means Better Hep C Treatment Finally Available As the first FDA approved Hepatitis C protease inhibitor, boceprevir (Victrelis) has cleared the final hurdle and can now improve the general public’s odds for beating the Hepatitis C virus. Read more. May 23rd Could Bring Approval for Vertex's Hep C Drug Due to a solid Phase III program, Vertex’s telaprevir (Incivek) could receive approval to treat Hepatitis C before the end of May 2011. Read more. Those with Hepatitis B or C Need Hepatitis A Immunity To prevent the serious danger Hepatitis A poses to those with preexisting chronic liver disease, immunity through previous illness or vaccination is an absolute necessity. Read more. Hepatitis C Screening Advised According to Age Group By testing Americans born from 1946 to 1970 for Hepatitis C, a statistical model claims that thousands of lives could be saved. Read more. Your Opinion Wanted: Eurythmy is considered to be both a form of energy medicine and the art of visible speech and song, and it may help those with Hepatitis C by delivering an active approach toward liver wellness. Have you ever tried eurythmy therapy? YesNo VISIT the Eurythmy Therapy poll today. Learn how Chronic Hepatitis C Sufferers Might Benefit from Eurythmy. We asked, you responded: Did you know that Traditional Chinese Medicine strategies aimed at fortifying liver blood can also improve the eye’s nutrition and thus nourish the macula? 23%: Yes77%: No To learn why preserving vision and maintaining liver health share several commonalities – click here. UPDATE: Discover how using Traditional Chinese Medicine can help improve liver and eye health. To learn even more about Hepatitis C and what you can do about it, visit Hepatitis-Central.com. You'll find more than 2,750 pages of in-depth information for HCV patients and their families, caregivers and health professionals. If you would like to review an article you saw in one of these recent Research & Treatment News updates, or would like to search through any of the archived, in-depth news and commentary pages, you ought to browse Hepatitis C Information Central at Hepatitis-Central.com. Note: LiverSupport Health News, our “sister†e-newsletter, gives you valuable lifestyle suggestions and news-you-can-use from our LiverSupport.com editors. Just click here to sign up for LiverSupport Health News, and learn even more about supporting liver health for you and your family. Yours in health,Editors@...www.Hepatitis-Central.com1-800-364-5722 Do you have a friend or relative who would find the information in this Research & Treatment News update useful? You can forward this email to them, so they can begin reading all the latest hepatitis research and liver support news. If you're not a current subscriber, click here to sign up today. We value your privacy. We will not rent your e-mail to anyone. Review our Privacy Policy. 2011 Hepatitis-Central.com. Hepatitis-Central.com2331 State Route 17KMontgomery, NY 125491-800-364-5722 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.